Stelzer Laurie insider trades
Stelzer Laurie has filed 20 Form 4s with the SEC that we hold, for PMV Pharmaceuticals, Inc. (PMVP) (Director), MRTX (Chief Financial Officer), Spyre Therapeutics, Inc. (SYRE) (Director) and ARNA (EVP & Chief Financial Officer), among 7 companies in all. Across all of them we count 0 purchases worth $0 and 1 sale worth $172.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 4,647 shares of MRTX worth $172.2K, dated 2023-06-02. The first filing on our record is dated 2022-01-05 and the latest 2026-06-18.
PMV Pharmaceuticals, Inc. (PMVP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MRTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-02 | S, sale reported on Form 4 | 4,647 | $172.2K | 2023-06-02 |
Spyre Therapeutics, Inc. (SYRE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ARNA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MBX Biosciences, Inc. (MBX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Sionna Therapeutics, Inc. (SION)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
SURF
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1644348) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms